Effect of Tannin-Rich Extract of Chasmanthera dependens on Piroxicam-induced Liver Damage in Male Wistar Rats

Tijani Stephanie Abiola, Olori Ogaraya David, Farombi Ebenezer Olatunde

Abstract


Background: Piroxicam is one of the nonsteroidal anti-inflammatory drugs used as antipyretic, analgesic and anti-inflammatory drug often used for the relief of nonspecific fever condition and in arthritis. This study investigated the protective potential of tannin-rich extract of Chasmanthera dependens (TRECDS) against piroxicam-induced hepatotoxicity in male Wistar rats.

Materials and Methods: Thirty two rats were divided into four groups. Group 1 received normal saline and served as the control group, group 2 were given 20 mg/kg piroxicam only, while groups 3 and 4 were given 20 mg/kg piroxicam with the addition of 200 and 400 mg/kg of tannin-rich extract of Chasmanthera dependens, respectively. All rats were treated orally once daily for ten days.

Results: Administration of piroxicam caused liver atrophy demonstrated by significant rise in serum alanine aminotransferase (ALT), alkaline phosphatase (ALP), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), glucose-6-phosphate dehydrogenase (G6PDH) levels of albumin (ALB), bilirubin (BIL), total cholesterol (TCHOL), triglyceride (TRIGS) and low-density lipoprotein (LDL). Piroxicam also decreased high-density lipoprotein (HDL) level, enzymatic and nonenzymatic antioxidant levels significantly (p>0.05) with attendant increase in oxidative stress indices in the liver of rats compared with control group. Histological assessment reveled severe damaged to the liver of rats. However, co-administration with TRECDS reversed these observations as evidenced in the histological results.

Conclusion: The findings of this study showed that exposure of rats to piroxicam provoked damage to the liver via oxidative damage and TRECDS has the potential of ameliorating the damage.

Keywords: hepatotoxicity, piroxicam, Chasmanthera dependens, oxidative stress


Full Text:

PDF

References


Di Salvo A, Giorgi M, Nannarone S, Lee HK, Coralini J, dellaRocca G. Postoperative pharmacokinetics of meloxicam in horses after surgery for colic syndrome. J Vet Pharmacol Ther. 2018; 41(3): 369-73, CrossRef.

Benazir S, Ghosh D, Chattyopadhyay A. Protective effect of antioxidant rich aqueous curry leaf (Murraya koenigii) extract against gastro-toxic effects of piroxicam in male Wistar rats. Toxicol Rep. 2014; 1: 987-1003, CrossRef.

Abdeen A, Aboubakr M, Elgazzar D, AbdoM, Abdelkader A, Ibrahim S, Elkomy A. Rosuvastatin attenuates piroxicam-mediated gastric ulceration and hepato-renal toxicity in rats. Biomed Pharmacother. 2019: 110: 895-905, CrossRef.

Sriuttha P, Sirichanchuen B, Permsuwan U. Hepatotoxicity of nonsteroidal anti-inflammatory drugs: a systematic review of randomized controlled trials. Int J Hepatol. 2018: 2018: 5253623, CrossRef.

Neha R, Munna S, Sanghamitra R. Piroxicam, a traditional non-steroidal anti-inflammatory drug (NSAID) causes apoptosis by ROS mediated Akt activation. Pharmacologic Rep. 2015; 67(6): 1215-23, CrossRef.

Adedara IA, Teberen R, Ebokaiwe AP, Ehwerhemuepha T, Farombi EO. Induction of oxidative stress in liver and kidney of rats exposed to Nigerian bonny light crude oil. Environ Toxicol. 2012; 27(6): 372-9, CrossRef.

Polidori MC, Stahl W, Eichler O, Niestroj I, Sies H. Profiles of antioxidants in human plasma. Fr Rad Biol Med. 2001; 30(5): 456-62, CrossRef.

Adeyemi DO, Ukwenya VO, Obuotor EM, Adewole SO. Anti-hepatotoxic activities of Hibiscus sabdariffa L. in animal model of streptozotocin diabetes-induced liver damage. BMC Compl Altern Med 2014; 14: 277, CrossRef.

Huang TW, Chang CL, Kao ES, Lin JH. Effect of Hibiscus sabdariffa extract on high fat diet-induced obesity and liver damage in hamsters. Food Nutr Res. 2015; 59: 29018, CrossRef.

Mosango DM. Chasmanthera dependens hochst. In: Schmelzer GH, Gurib-Fakim A, editors. Plant Resources of Tropical Africa/Ressources végétales de l’Afrique tropicale. Wageningen: PROTA; 2008. p.23-45.

Ogunlesi M, Okei W, Ademoye M. Medicinal plants used in treating eye infections in Nigeria. In: Odugbemi T, editor. A Textbook of Medicinal Plants from Nigeria. Lagos: University of Lagos Press; 2008. p.299-317.

Morebise O, Awe EO, Makinde JM, Olajide OA. Evaluation of the anti-inflammatory and analgesic properties of Chasmanthera dependens leaf methanol extract. Fitoterapia. 2001; 72(5): 497-502, CrossRef.

Fatokun OT, Wojuola TE, Esievo KB, Kunle OF. Medicinal plants used in the management of asthma: a review. EJPMR. 2016; 3(7): 82-92, article.

US Department of Health and Human Services. Policy on Humane Care and Use of Laboratory Animals. Washington: US Department of Health and Human Services; 1996.

Aithal GP, Day CP. Nonsteroidal anti-inflammatory drug-induced hepatotoxicity. Clin Liver Dis. 2007; 11(3): 563-75, CrossRef.

Misra HP, Fridovich I. The role of superoxide anion in the auto-oxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972; 247(10): 3170-5, CrossRef.

Sinha AK. Colorimetric Assay of Catalase. Anal Biochem. 1972; 47(2): 389-94, CrossRef.

Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacol. 1974; 11(3): 151-69, CrossRef.

Farombi EO, Tahnteng JG, Agboola AO, Nwankwo JO, Emerole GO. Chemoprevention of 2-acetylaminofluorene-induced hepatotoxicity and lipid peroxidation in rats by kolaviron-a Garcinia kola seed extract. Food Chem Toxicol. 2000; 38(6): 535-41, CrossRef.

Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem. 1951; 193(1): 265–275, CrossRef.

Songur A, Akpolat N, Kus I, Ozen OA, Zararsiz I, Sarsilmaz M. The effects of the inhaled formaldehyde during the early postnatal period in the hippocampus of rats: a morphological and Immunohistochemical study. Neurosci Res Comm. 2003; 33(3): 168-178, CrossRef.

Moore KL, Dalley AF. Clinically Oriented Anatomy. 4th ed. Philadelphia: Lippincot Williams and Williams; 1999, article.

Ghouri N, Preiss D, Sattar N. Liver enzymes, non-alcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatol. 2010; 52(3): 1156-61, CrossRef.

Singh A, Bhat TK, Sharma OP. Clinical biochemistry of hepatotoxicity. J Clinic Toxicol . 2011; S4: 001, CrossRef.

Sobeh M, Mahmoud MF, Abdelfattah MAO, El-Beshbishy HA, El-Shazly AM, Wink M. Hepatoprotective and hypoglycemic effects of a tannin-rich extract from Ximenia americana var. caffra root. Int J Phythe Phytpharm. 2017; 33: 36-42, CrossRef.

Hussaini SH, Farrington EA. Idiosyncratic drug-induced liver injury: an update on the 2007 overview. Expert Opin Drug Saf. 2014; 13(1): 67-81, CrossRef.

Lina MAM, Amal KA. Biological effects of different doses of Piroxicam in albino male rats. Iraqi J Sci. 2017; 58(2c): 1009-19, CrossRef.

Franciscus A. An Overview of the Liver. Minnesota: Health Care Savings Plan (HCSP); 2015.

Swagata P, Bhattacharjee A, Mukherjee S, Bhattacharya K, Khowala S. Antioxidant and hepatoprotective activity of ethanolic extract of Alocasia indica Tuber. AJPCT. 2014; 2(2): 191-208, article.

Yakubu MT, Akanji MA, Oladiji AT. Alterations in serum lipid profile of male rats by oral administration of aqueous extract of Fadogia agrestis stem. Res J Med Plant. 2008; 2(2): 66-73, CrossRef.

Adedara IA, Farombi EO. Induction of oxidative damage in the testes and spermatozoa and hematotoxicity in rats exposed to multiple doses of ethylene glycol monoethyl ether. Hum Exper Toxicol. 2010; 29(10): 801-12, CrossRef.

Avery SV. Molecular targets of oxidative stress. Biochem J. 2011; 434(2): 201-10, CrossRef.

Sangeetha LAR, Samixaben Patel D, Chetan Pandanaboina S. Hepato-protective effects of blue-green alga spirulina platensis on diclofenac-induced liver injury in rats. Mal J Nutr. 2016; 22(2): 289-99, article.




DOI: https://doi.org/10.21705/mcbs.v5i1.186

Indexed by:

                     

                    

                    


Cell and BioPharmaceutical Institute